glp-1 receptor agonists benefits and cardiovascular outcome trials: An update GLP-1: Genetic Variants Related to

2019, doi: 10.3389/fendo.2019.00376

[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Orringer K

PD prevalence is continually increasing, and by 2040, about 12 million people are expected to be diagnosed with this devastating disease

Though these drugs are generally less effective than newer alternatives, they can work for many people: Orlistat (Alli, Xenical) reduces the amount of fat absorbed by the intestines

This builds on his work to understand 'how circulating GLP-1 can produce multiple actions, both directly and indirectly, on multiple organs' which he has pursued for many years with colleagues (McLean, Wong, Campbell)

The Importance of Consulting Healthcare Professionals If you're considering transitioning from medication like GLP-1 agonists to natural alternatives or integrating supplements into your regimen, its crucial to consult with healthcare professionals first